Mustang bio, inc. (MBIO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15
Revenue - related party

-

-

0

0

-

-

0

0

-

-

0

0

0

-

-

-

-

-

Operating expenses:
Research and development

9,314

8,950

7,309

6,823

6,960

7,939

5,316

3,557

4,292

2,555

2,188

2,494

706

750

569

582

567

570

Research and development - licenses acquired

250

-

700

-

450

-

1,000

-

-

-

-

-

-

-

-

-

-

-

Research and development - licenses acquired

-

-

-

200

-

-

-

0

75

10,058

300

1,500

575

6,079

0

0

0

0

General and administrative

1,956

2,050

1,987

3,189

2,344

1,676

1,340

1,683

2,060

3,117

4,596

1,671

2,025

1,002

1,101

458

255

88

Total operating expenses

11,520

15,923

9,996

10,212

9,754

11,900

7,656

5,240

6,427

15,730

7,084

5,665

3,306

-

1,670

1,040

-

658

Loss from operations

-11,520

-15,923

-9,996

-10,212

-9,754

-11,900

-7,656

-5,240

-6,427

-15,730

-7,084

-5,665

-3,306

-7,831

-1,670

-1,040

-822

-658

Other income (expense)
Interest income

263

318

406

387

152

138

138

147

146

137

144

134

90

16

0

0

0

-

Interest income - related party

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

Interest expense - related party

-

-

-

-

-

-

-

-

-

-

-

-

-2

-

-46

-93

-

-

Interest expense - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81

58

Interest expense

600

604

578

574

11

8

0

0

0

-

-

-

-

-

156

-

-

0

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

-

-

0

Total other income (expense)

-337

-286

-172

-187

141

130

138

147

146

-

-

136

88

-917

-200

-93

-81

-58

Net Loss

-11,857

-16,209

-10,168

-10,399

-9,613

-11,770

-7,518

-5,093

-6,281

-15,601

-6,940

-5,529

-3,218

-8,748

-1,870

-1,133

-903

-716

Net loss per common share outstanding, basic and diluted

-0.28

-0.41

-0.25

-0.29

-0.34

-0.43

-0.28

-0.19

-0.24

-0.62

-0.27

-0.21

-0.14

-0.76

-0.19

-0.11

-0.09

-0.07

Weighted average number of common shares outstanding, basic and diluted

41,971

40,119

39,875

36,306

27,945

27,175

27,146

27,087

26,387

26,243

26,186

26,180

22,401

13,715

10,089

10,250

10,052

10,000